How the pandemic and George Floyd made clinical trial diversity a priority
July 05, 2022
![mc-drug-discovery-trends-logo](https://clario.com/wp-content/uploads/2022/07/mc-drug-discovery-trends-logo.png)
Clario Chief Diversity, Inclusion & Sustainability Officer Otis Johnson, Ph.D., M.P.A., sat down with Drug Discovery and Development to discuss how COVID-19 shone a light on the lack of diversity in clinical trials. Read the full article here.